Craft
Amgen

Amgen

Manufacturing Facilities (Foreign)

5

FY, 2020

Revenue

$26 B

FY, 2021

Market Capitalization

$130 B

2022-09-19

Amgen Summary

Company summary

Overview
Amgen (formerly known as Applied Molecular Genetics) is a biotech company discovering, developing, manufacturing, and delivering human therapeutics products. It focuses on oncology and hematology, cardiovascular, inflammation, bone health, and neuroscience diseases. Its major brands include Aimovig, Aranesp, BLINCYTO, Corlanor, KYPROLIS, EVENITY, and NEUPOGEN.
Type
Public
Founded
1980
HQ
Thousand Oaks, CA, US | view all locations
Website
https://www.amgen.com/
ESG rating
out of 100 | View all ESG data
Sectors

Key people

  • Robert A Bradway

    Robert A Bradway, Chairman and Chief Executive Officer

  • Victoria H Blatter

    Victoria H Blatter, Senior Vice President, Global Government Affairs and Policy

    • Judy Brown

      Judy Brown, Senior Vice President, Corporate Affairs

    • Jackie Elbonne

      Jackie Elbonne, Senior Vice President, Quality and Chief Quality Officer

    Operating MetricsView all

    Distribution Centers (Foreign)

    3

    FY, 2020

    Countries

    100

    FY, 2020

    Patents (US)

    31
    8.8%

    FY, 2020

    LocationsView all

    66 locations detected

    • Thousand Oaks, CA HQ

      United States

      1 Amgen Center Dr

    • Cambridge, MA

      United States

      360 Binney St

    • Louisville, KY

      United States

      12000 Plantside Dr

    • South San Francisco, CA

      United States

      1120 Veterans Blvd

    • Tampa, FL

      United States

      2202 N Westshore Blvd

    • Washington, DC

      United States

      601 13th St NW 12th Floor

    and 60 others

    Amgen Financials

    Summary financials

    Revenue (Q2, 2022)
    $6.6B
    Gross profit (Q2, 2022)
    $5.1B
    Net income (Q2, 2022)
    $1.3B
    Cash (Q2, 2022)
    $5.2B
    EBIT (Q2, 2022)
    $2.2B
    Enterprise value
    $161.3B

    Footer menu